Respiratory effects of glutamate receptor antagonists in neonate and adult mammals

被引:25
|
作者
Borday, V
Foutz, AS [1 ]
Nordholm, L
Denavit-Saubié, M
机构
[1] CNRS, Inst Alfred Fessard, F-91198 Gif Sur Yvette, France
[2] Novo Nordisk AS, Div Pharmaceut, Malov, Denmark
关键词
respiration; NBQX (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline; dizocilpine; neonate; development; (Cat); (Mouse);
D O I
10.1016/S0014-2999(98)00160-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We determined the conditions (immaturity, species, anesthesia, receptor blockade selectivity) under which glutamate receptor blockade produces respiratory depression in mammals. In unrestrained 0- to 2-day-old neonate and adult mice and cats, ventilation was measured by the barometric method, before and after separate or sequential administration of a non-NMDA receptor antagonist, NBQX (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline, 2-200 mg kg(-1) in mice, 10-40 mg kg(-1) in cats), and a NMDA receptor antagonist, dizocilpine (3 mg kg(-1) in mice, 0.15-1.0 mg kg(-1) in cats). NBQX or dizocilpine alone did not decrease ventilation in awake adults, but NBQX strongly depressed ventilation in neonate awake mice and in adult anesthetized animals. Given together: dizocilpine and NBQX always profoundly depressed ventilation by producing a lethal apnea in neonate mice, and an apneustic pattern of breathing in adults of both species and in neonate cats. We conclude that blockade of either NMDA or non-NMDA receptors is innocuous in awake adults. The factors which may potentiate respiratory depression are (1) anesthesia, (2) immaturity, and (3) combined blockade of both receptors types. The mechanism of depression is species-dependent and age-dependent. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:235 / 246
页数:12
相关论文
共 50 条
  • [21] New perspectives on Glutamate Receptor Antagonists as Antidepressants
    Chung, ChiHye
    ARCHIVES OF PHARMACAL RESEARCH, 2012, 35 (04) : 573 - 577
  • [22] A new type of metabotropic glutamate receptor antagonists
    Kanstrup, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 107 - MEDI
  • [23] Neuroprotective potential of ionotropic glutamate receptor antagonists
    Danysz, Wojciech
    Parsons, Chris G.
    NEUROTOXICITY RESEARCH, 2002, 4 (02) : 119 - 126
  • [24] New perspectives on glutamate receptor antagonists as antidepressants
    ChiHye Chung
    Archives of Pharmacal Research, 2012, 35 : 573 - 577
  • [25] Glutamate receptor antagonists with the potential for migraine treatment
    Ferrari, Anna
    Rustichelli, Cecilia
    Baraldi, Carlo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (12) : 1321 - 1330
  • [26] Neuroprotective potential of ionotropic glutamate receptor antagonists
    Wojciech Danysz
    Chris G. Parsons
    Neurotoxicity Research, 2002, 4 : 119 - 126
  • [27] REDUCTION OF DESENSITIZATION OF A GLUTAMATE IONOTROPIC RECEPTOR BY ANTAGONISTS
    GEOFFROY, M
    LAMBOLEZ, B
    AUDINAT, E
    HAMON, B
    CREPEL, F
    ROSSIER, J
    KADO, RT
    MOLECULAR PHARMACOLOGY, 1991, 39 (05) : 587 - 591
  • [29] Pharmacology of glutamate receptor antagonists in the kindling model
    Loscher, W
    KINDLING 5, 1998, 48 : 435 - 449
  • [30] Metabotropic glutamate receptor antagonists for nicotine dependence
    Markou, A
    Kenny, PJ
    Paterson, NE
    Semenova, S
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S3 - S4